Market Overview

21 Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

  • Gevo, Inc. (NASDAQ: GEVO) shares rose 37.8 percent to $17.50 in pre-market trading. Gevo shares surged around 262 percent on Monday after the EPA announced it has approved up to a 16 percent blend of isobutanol for use in automobiles.
  • Foundation Medicine, Inc. (NASDAQ: FMI) shares rose 28.3 percent to $136.60 in pre-market trading after Roche announced plans to acquire outstanding shares of FMI for $137 per share in cash.
  • Astrotech Corporation (NASDAQ: ASTC) rose 27.2 percent to $2.48 in pre-market trading after the company’s 1st Detect subsidiary disclosed that its TRACER 1000 explosives trace detector will enter the European Civil Aviation Conference Common Evaluation Process for airport checkpoint screening.
  • Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) rose 26.5 percent to $3.10 in pre-market trading after the company reported a multi-year deal with Canopy Growth for supplementing of Canopy's extraction, refinement, and extract product formulation capacity.
  • Viveve Medical, Inc. (NASDAQ: VIVE) shares rose 20.7 percent to $4.60 in pre-market trading after reporting six-month data from stress urinary incontinence feasibility study. Eighty-three percent of women treated experienced an improvement in one-hour pad weight and achieved clinically meaningful benefit across all quality of life outcome measures.
  • InterXion Holding N.V. (NYSE: INXN) rose 12.1 percent to $72 in pre-market trading.
  • Novus Therapeutics, Inc. (NASDAQ: NVUS) rose 11.8 percent to $6.71 in pre-market trading after the company disclosed that it has received the FDA guidance at a Type-C meeting for Op02 for the treatment and prevention of otitis media.
  • Secoo Holding Ltd - ADR (NASDAQ: SECO) shares rose 6.3 percent to $10.20 in pre-market trading following Q1 results. Secoo posted quarterly earnings of $0.10 per share on sales of $127.936 million.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) rose 5.1 percent to $3.14 in pre-market trading after declining 6.27 percent on Monday.
  • Arcadia Biosciences, Inc. (NASDAQ: RKDA) shares rose 5 percent to $8.56 in pre-market trading after falling 1.81 percent on Monday.
  • Celyad SA (NASDAQ: CYAD) rose 4.7 percent to $27.75 in pre-market trading after surging 17.03 percent on Friday. Verastem presented Duvelisib data at the EHA 2018 Annual Meeting.
  • Puxin Limited (NYSE: NEW) rose 4.2 percent to $30 in pre-market trading after climbing 37.14 percent on Monday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Sea Limited (NYSE: SE) fell 13.6 percent to $13.45 in the pre-market trading session after the company disclosed that it has raised $575 million in convertible notes offering.
  • Tellurian Inc. (NASDAQ: TELL) shares fell 10.1 percent to $9.78 in pre-market trading. Tellurian priced its 12 million share offering of common stock for gross proceeds of $118.8 million.
  • PagSeguro Digital Ltd. (NYSE: PAGS) shares fell 9.1 percent to $29.29 in pre-market trading after dropping 3.75 percent on Monday.
  • VAALCO Energy, Inc. (NYSE: EGY) shares fell 6.7 percent to $2.38 in pre-market trading.
  • Nektar Therapeutics (NASDAQ: NKTR) shares fell 6.2 percent to $54.78 in pre-market trading.
  • Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) shares fell 6.1 percent to $14 in pre-market trading after dropping 9.09 percent on Monday.
  • Frontline Ltd. (NYSE: FRO) fell 5.5 percent to $5.68 in pre-market trading after climbing 9.31 percent on Monday.
  • RSP Permian, Inc. (NYSE: RSPP) fell 5.5 percent to $38.58 in pre-market trading after climbing 2.41 percent on Monday.
  • Huami Corporation (NYSE: HMI) fell 4.6 percent to $10.60 in pre-market trading after declining 4.64 percent on Monday.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas

 

Related Articles (ASTC + CYAD)

View Comments and Join the Discussion!

Benzinga Pro's 5 Stocks To Watch Today

Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares